Patents by Inventor Eric Jarvis
Eric Jarvis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240094741Abstract: Disclosed herein are a method and apparatus for automated following behind a lead vehicle. The lead vehicle navigates a path from a starting point to a destination. The lead vehicle and the following vehicle are connected via V2V communication, allowing one or more following vehicles to detect the path taken by the lead vehicle. A computerized control system on the following vehicle (a Follow-the-Leader, or FTL, system) allows the following vehicle to mimic the behavior of the lead vehicle, with the FTL system controlling steering to guide the following vehicle along the path previously navigated by the lead vehicle. In some embodiments, the lead vehicle and following vehicle may both use Global Navigation Satellite System (GNSS) position coordinates. In some embodiments, the following vehicle may also have a system of sensors to maintain a gap between the following and lead vehicles.Type: ApplicationFiled: April 25, 2023Publication date: March 21, 2024Applicant: Peloton Technology, Inc.Inventors: Shad Laws, Joshua Switkes, Art Gavrysh, Marc Tange, Mark Herbert, Colleen Twitty, Dean Hogle, Andrew Tamoney, Eric Monsler, Carlos Rosario, Oliver Bayley, Richard Pallo, Louis Donayre, Laurenz Laubinger, Brian Smartt, Joyce Tam, Brian Silverman, Tabitha Jarvis, Murad Bharwani, Steven Erlein, Austin Schuh, Mark Luckevich
-
Publication number: 20220278966Abstract: A computer that provides a secure, virtual personalized network (SVPN) with one or more preconfigured digital wallets for a first user in the SVPN is described. Notably, the computer may execute a virtual machine that provides a container for the SVPN of the first user, and the first electronic device associated with the first user may execute an instance of an application that facilitates secure communication in the SVPN and/or conducting of one or more distributed secure transactions (such as a transaction associated with a cryptocurrency or a non-fungible token or NFT) via the SVPN. Moreover, the virtual machine may provide a container for the SVPN of the first user. This container may include the one or more preconfigured digital wallets associated with the first user, where a given preconfigured digital wallet includes cryptographic keys and a distributed ledger for use in conducting the one or more distributed secure transactions.Type: ApplicationFiled: May 16, 2022Publication date: September 1, 2022Applicant: Neone, Inc.Inventors: Dave M. Glassco, Karl Eric Jarvis
-
Publication number: 20220278967Abstract: A computer that provides one or more verified personas for a distributed token (such as a non-fungible token or NFT) of a first user is described. Notably, the computer may provide the one or more verified personas for the first user that are based at least in part on their account(s) with a provider of a secure, virtual private network (SVPN) of the first user. Consequently, the identity of the first user may be known to the provider. However, the one or more verified personas may obfuscate the known identity of the first user when conducting one or more discrete secure transactions (such as a transaction associated with a cryptocurrency or the NFT) using or associated with the distributed token. In particular, the first user may associate or link the one or more verified personas with the distributed token, thereby providing the benefits of privacy and selective (as-needed) identification.Type: ApplicationFiled: May 16, 2022Publication date: September 1, 2022Applicant: Neone, Inc.Inventors: Dave M. Glassco, Karl Eric Jarvis
-
Patent number: 10036051Abstract: Nucleic acid sequences encoding chimeric polypeptides that exhibit enhanced cellulase activities are disclosed herein. These nucleic acids may be expressed in hosts such as fungi, which in turn may be cultured to produce chimeric polypeptides. Also disclosed are chimeric polypeptides and their use in the degradation of cellulosic materials.Type: GrantFiled: May 12, 2017Date of Patent: July 31, 2018Assignee: Alliance for Sustainable Energy, LLCInventors: William S. Adney, Gregg T. Beckham, Eric Jarvis, Michael E. Himmel, Stephen R. Decker, Jeffrey G. Linger, Kara Podkaminer, John O. Baker, Larry Taylor, II, Qi Xu, Arjun Singh
-
Publication number: 20170247731Abstract: Nucleic acid sequences encoding chimeric polypeptides that exhibit enhanced cellulase activities are disclosed herein. These nucleic acids may be expressed in hosts such as fungi, which in turn may be cultured to produce chimeric polypeptides. Also disclosed are chimeric polypeptides and their use in the degradation of cellulosic materials.Type: ApplicationFiled: May 12, 2017Publication date: August 31, 2017Inventors: William S. ADNEY, Gregg T. BECKHAM, Eric JARVIS, Michael E. HIMMEL, Stephen R. DECKER, Jeffrey G. LINGER, Kara PODKAMINER, John O. BAKER, Larry TAYLOR, II, Qi XU, Arjun SINGH
-
Patent number: 9683248Abstract: Nucleic acid sequences encoding chimeric polypeptides that exhibit enhanced cellulase activities are disclosed herein. These nucleic acids may be expressed in hosts such as fungi, which in turn may be cultured to produce chimeric polypeptides. Also disclosed are chimeric polypeptides and their use in the degradation of cellulosic materials.Type: GrantFiled: December 17, 2012Date of Patent: June 20, 2017Assignee: Alliance for Sustainable Energy, LLCInventors: William S. Adney, Gregg T. Beckham, Eric Jarvis, Michael E. Himmel, Stephen R. Decker, Jeffrey G. Linger, Kara Podkaminer, John O. Baker, Larry Taylor, II, Qi Xu, Arjun Singh
-
Publication number: 20170044554Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes, L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. A yeast strain engineered to metabolize arabinose through a novel pathway is also disclosed. Methods of producing ethanol include utilizing these modified yeast strains.Type: ApplicationFiled: September 18, 2014Publication date: February 16, 2017Inventors: Min ZHANG, Arjun SINGH, Pirkko SUOMINEN, Eric KNOSHAUG, Mary Ann FRANDEN, Eric JARVIS
-
Publication number: 20140322765Abstract: Nucleic acid sequences encoding chimeric polypeptides that exhibit enhanced cellulase activities are disclosed herein. These nucleic acids may be expressed in hosts such as fungi, which in turn may be cultured to produce chimeric polypeptides. Also disclosed are chimeric polypeptides and their use in the degradation of cellulosic materials.Type: ApplicationFiled: December 17, 2012Publication date: October 30, 2014Inventors: William S. Adney, Gregg T. Beckham, Eric Jarvis, Michael E. Himmel, Stephen R. Decker, Jeffrey G. Linger, Kara Podkaminer, John O. Baker, Larry Taylor, II, Qi Xu, Arjun Singh
-
Patent number: 8841090Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. A yeast strain engineered to metabolize arabinose through a novel pathway is also disclosed. Methods of producing ethanol include utilizing these modified yeast strains.Type: GrantFiled: January 17, 2013Date of Patent: September 23, 2014Assignee: Alliance for Sustainable Energy, LLCInventors: Min Zhang, Arjun Singh, Pirkko Suominen, Eric Knoshaug, Mary Ann Franden, Eric Jarvis
-
Patent number: 8372626Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. A yeast strain engineered to metabolize arabinose through a novel pathway is also disclosed. Methods of producing ethanol include utilizing these modified yeast strains.Type: GrantFiled: October 21, 2010Date of Patent: February 12, 2013Assignee: Alliance for Sustainable Energy, LLCInventors: Min Zhang, Arjun Singh, Pirkko Suominen, Eric Knoshaug, Mary Ann Franden, Eric Jarvis
-
Publication number: 20120129241Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. A yeast strain engineered to metabolize arabinose through a novel pathway is also disclosed. Methods of producing ethanol include utilizing these modified yeast strains.Type: ApplicationFiled: October 21, 2010Publication date: May 24, 2012Applicant: ALLIANCE FOR SUSTAINABLE ENGERGY, LLCInventors: MIN ZHANG, ARJUN SINGH, PIRKKO SUOMINEN, ERIC KNOSHAUG, MARY ANN FRANDEN, ERIC JARVIS
-
Patent number: 8071564Abstract: Provided herein are a variety of methods and compositions for regulating angiogenesis, such methods and compositions being useful in a variety of applications where modulation of vascular formation is useful, including, but not limited to, treatments for ischemia and wound healing. Certain of the methods and compositions accomplish this by using various zinc finger proteins that bind to particular target sites in one or more VEGF genes. Nucleic acids encoding the zinc finger proteins are also disclosed. Methods for modulating the expression of one or more VEGF genes with the zinc finger proteins and nucleic acids are also disclosed. Such methods can also be utilized in a variety of therapeutic applications that involve the regulation of endothelial cell growth. Pharmaceutical compositions including the zinc finger proteins or nucleic acids encoding them are also provided.Type: GrantFiled: September 3, 2009Date of Patent: December 6, 2011Assignee: Sangamo Biosciences, Inc.Inventors: Edward Rebar, Andrew Jamieson, Qiang Liu, Pei-Qi Liu, Alan Wolffe, Stephen P. Eisenberg, Eric Jarvis
-
Patent number: 7846712Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. Methods of producing ethanol include utilizing these modified yeast strains.Type: GrantFiled: March 19, 2007Date of Patent: December 7, 2010Assignee: Alliance for Sustainable Energy, LLCInventors: Min Zhang, Arjun Singh, Eric Knoshaug, Mary Ann Franden, Eric Jarvis, Pirkko Suominen
-
Publication number: 20100144041Abstract: An L-arabinose utilizing yeast strain is provided for the production of ethanol by introducing and expressing bacterial araA, araB and araD genes. L-arabinose transporters are also introduced into the yeast to enhance the uptake of arabinose. The yeast carries additional genomic mutations enabling it to consume L-arabinose, even as the only carbon source, and to produce ethanol. Methods of producing ethanol include utilizing these modified yeast strains.Type: ApplicationFiled: March 19, 2007Publication date: June 10, 2010Applicant: MIDWEST RESEARCH INSTITUTEInventors: Min Zhang, Arjun Singh, Pirkko Suominen, Eric Knoshaug, Mary Ann Franden, Eric Jarvis
-
Publication number: 20100093838Abstract: Provided herein are a variety of methods and compositions for regulating angiogenesis, such methods and compositions being useful in a variety of applications where modulation of vascular formation is useful, including, but not limited to, treatments for ischemia and wound healing. Certain of the methods and compositions accomplish this by using various zinc finger proteins that bind to particular target sites in one or more VEGF genes. Nucleic acids encoding the zinc finger proteins are also disclosed. Methods for modulating the expression of one or more VEGF genes with the zinc finger proteins and nucleic acids are also disclosed. Such methods can also be utilized in a variety of therapeutic applications that involve the regulation of endothelial cell growth. Pharmaceutical compositions including the zinc finger proteins or nucleic acids encoding them are also provided.Type: ApplicationFiled: September 3, 2009Publication date: April 15, 2010Applicant: Sangamo BioSciences, Inc.Inventors: Edward Rebar, Andrew Jamieson, Qiang Liu, Pei-Qi Liu, Alan Wolffe, Stephen P. Eisenberg, Eric Jarvis
-
Patent number: 7667019Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.Type: GrantFiled: April 6, 2007Date of Patent: February 23, 2010Assignee: Heska CorporationInventors: Nancy Wisnewski, Anna M. Becher, Eric Jarvis
-
Patent number: 7605140Abstract: Provided herein are a variety of methods and compositions for regulating angiogenesis, such methods and compositions being useful in a variety of applications where modulation of vascular formation is useful, including, but not limited to, treatments for ischemia and wound healing. Certain of the methods and compositions accomplish this by using various zinc finger proteins that bind to particular target sites in one or more VEGF genes. Nucleic acids encoding the zinc finger proteins are also disclosed. Methods for modulating the expression of one or more VEGF genes with the zinc finger proteins and nucleic acids are also disclosed. Such methods can also be utilized in a variety of therapeutic applications that involve the regulation of endothelial cell growth. Pharmaceutical compositions including the zinc finger proteins or nucleic acids encoding them are also provided.Type: GrantFiled: April 26, 2005Date of Patent: October 20, 2009Assignee: Sangamo Biosciences, Inc.Inventors: Edward Rebar, Andrew Jamieson, Qiang Liu, Pei-Qi Liu, Alan Wolffe, Stephen P. Eisenberg, Eric Jarvis
-
Patent number: 7560440Abstract: Provided herein are a variety of methods and compositions for regulating angiogenesis, such methods and compositions being useful in a variety of applications where modulation of vascular formation is useful, including, but not limited to, treatments for ischemia and wound healing. Certain of the methods and compositions accomplish this by using various zinc finger proteins that bind to particular target sites in one or more VEGF genes. Nucleic acids encoding the zinc finger proteins are also disclosed. Methods for modulating the expression of one or more VEGF genes with the zinc finger proteins and nucleic acids are also disclosed. Such methods can also be utilized in a variety of therapeutic applications that involve the regulation of endothelial cell growth. Pharmaceutical compositions including the zinc finger proteins or nucleic acids encoding them are also provided.Type: GrantFiled: July 14, 2006Date of Patent: July 14, 2009Assignee: Sangamo Bioschiences, Inc.Inventors: Edward Rebar, Andrew Jamieson, Qiang Liu, Pei-Qi Liu, Alan Wolffe, Stephen P. Eisenberg, Eric Jarvis
-
Publication number: 20070231894Abstract: The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.Type: ApplicationFiled: April 6, 2007Publication date: October 4, 2007Inventors: Nancy Wisnewski, Anna Becher, Eric Jarvis
-
Publication number: 20070151278Abstract: An evaporative chiller cooling water to below ambient wet bulb temperature. Sub-wet bulb chilling is achieved by pre-cooling incoming air upstream of the saturator. The incoming air is ambient air at ambient air temperature that is cooled using the coolness of the lower temperature outgoing air exiting the saturator. The pre-cooling lowers the temperature of the incoming air and lowers its wet bulb temperature below that of ambient air. The saturator water is chilled to below the ambient wet bulb temperature. The air in the saturator flows across the water as it gravity drips or flows from the top to the bottom of the saturator. The pre-cooled air flows across the saturator with the coolest air directed across the bottom of the saturator where the coldest water is flowing and with the hottest air directed across the top where the hottest water is flowing to provide gradient chilling.Type: ApplicationFiled: December 27, 2006Publication date: July 5, 2007Applicant: NEXAJOULE, INC.Inventor: Eric Jarvis